RATIONALE: @entity1652 spectrum disorders (NMOSD) is considered as an immune-mediated @entity6220 (CNS). Numerous @entity792 are frequently complicated with NMOSD and distinct clinical characteristics are noted in NMOSD @entity1 with other @entity792 . However, to our best knowledge, co-occurrence of NMOSD and @entity14628 is rarely identified. @entity1 CONCERNS: We presented a rare case of a 72-year-old female with 6-year history of @entity14628 , and 1-month history of @entity227 as well as chest zonethesia. @entity3951 ( @entity3951 ) antibodies was positive in the serum of the @entity1 . DIAGNOSES: With the addition of laboratory findings, iconography findings and physical examination results, the diagnosis of NMOSD was established according to the most recent diagnostic criteria. INTERVENTIONS AND OUTCOMES: With the treatment of intravenous immunoglobulin (IVIg), the @entity1 felt better at discharge without changing of expanded disability status scale (EDSS) score. LESSONS: The case indicates that NMOSD could co-occur with @entity14628 . The disturbance of immune system balance may explain this overlap. Further studies are warranted to reveal the mechanism and to explore whether @entity1 with NMOSD with and without @entity14628 have distinct clinical feature, drug responsiveness or prognosis.

@entity3951 positive XXXX spectrum disorders secondary to @entity14628 : A case report.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENT'] @entity6220 :: ('MESH:D020279', 'Disease') :: ['disorder in the central nervous system'] @entity227 :: ('MESH:D014786', 'Disease') :: ['blurred vision'] @entity1652 :: ('MESH:D009471', 'Disease') :: ['Neuromyelitis optica'] @entity792 :: ('MESH:D001327', 'Disease') :: ['autoimmune diseases'] @entity3951 :: ('361', 'Gene') :: ['Anti-aquaporin-4', 'AQP4'] @entity14628 :: ('MESH:D011696', 'Disease') :: ['thrombopenic purpura']
@entity1652 :: (MESH:D009471,Disease) :: ['neuromyelitis optica']
